Liver Disease Diagnostics Market Share 2031
PORTLAND, OREGON, UNITED STATES, August 7, 2023/EINPresswire.com/ — Rise in liver transplantation: In cases where liver damage is severe, liver transplantation becomes necessary. The demand for liver transplants has been increasing, leading to a surge in transplantation procedures and a need for immunosuppressive drugs to prevent organ rejection.
The global liver disease diagnostics market size was valued at $34.5 billion in 2021, and is projected to reach $62.6 billion by 2031, growing at a CAGR of 6.1% from 2022 to 2031.
Technological advancements in diagnosis and treatment: Advancements in medical technology have improved the diagnosis and treatment of liver diseases. Non-invasive diagnostic techniques, such as imaging and blood tests, help in early detection and monitoring of liver conditions. Additionally, novel therapies and drugs have been developed to target specific liver diseases.
Request Sample Copy of Report: https://www.alliedmarketresearch.com/request-sample/388
Market Drivers:
Increasing prevalence of liver diseases: Liver diseases, including hepatitis, cirrhosis, and NAFLD, have witnessed a rising prevalence globally. Factors such as viral infections, alcohol consumption, obesity, and lifestyle choices contribute to the growing burden of liver diseases, creating a higher demand for effective treatments.
Technological advancements in diagnosis and treatment: Advances in medical technology have led to improved diagnostic techniques for liver diseases. Non-invasive methods such as imaging, biomarker tests, and genetic testing facilitate early detection and accurate diagnosis. Additionally, advancements in treatment options, including pharmaceuticals, surgical procedures, and liver transplantation techniques, have enhanced patient outcomes.
Market Segmentation:
By Type of Liver Disease:
a. Viral Hepatitis (Hepatitis B, Hepatitis C, etc.)
b. Non-alcoholic Fatty Liver Disease (NAFLD) and Non-alcoholic Steatohepatitis (NASH)
c. Alcoholic Liver Disease
d. Autoimmune Liver Diseases (Autoimmune Hepatitis, Primary Biliary Cholangitis, etc.)
e. Liver Cirrhosis
f. Liver Cancer (Hepatocellular Carcinoma, Cholangiocarcinoma, etc.)
g. Others
By Treatment Type:
a. Pharmaceutical Drugs
Antiviral Drugs
Immunosuppressive Drugs
Hepatoprotective Drugs
Chemotherapy Drugs
Targeted Therapies
Others
b. Surgical Interventions
Liver Transplantation
Resection and Ablation Procedures
Others
c. Supportive Care
Symptom Management
Nutritional Support
Lifestyle Modifications
Palliative Care
Others
By Distribution Channel:
a. Hospitals
b. Specialty Clinics
c. Retail Pharmacies and Drug Stores
d. Online Pharmacies
e. Others
By Region:
a. North America (United States, Canada, and Mexico)
b. Europe (Germany, UK, France, Italy, Spain, etc.)
c. Asia Pacific (China, Japan, India, Australia, South Korea, etc.)
d. Latin America (Brazil, Argentina, Mexico, etc.)
e. Middle East and Africa
By End User:
a. Hospitals
b. Specialty Clinics
c. Ambulatory Surgical Centers
d. Research and Academic Institutes
e. Others
Request for Customization – https://www.alliedmarketresearch.com/request-for-customization/8790
Competitive Landscape:
Gilead Sciences Inc.
F. Hoffmann-La Roche Ltd.
AbbVie Inc.
Merck & Co., Inc.
Johnson & Johnson
Bristol-Myers Squibb Company
Novartis AG
Pfizer Inc.
Bayer AG
Intercept Pharmaceuticals, Inc.
Procure Complete Report at 20% Discount (258 Pages):
https://www.alliedmarketresearch.com/purchase-enquiry/388
Related Reports :
Pediatric Neurology Device Market
Thyroid Ablation Devices Market
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
David Correa
Allied Analytics LLP
1 800-792-5285
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn
